Li Xinyu, Zhu Riran, Liu Qian, Sun Henglai, Sheng Huagang, Zhu Liqiao
College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
Int J Biol Macromol. 2024 Dec;282(Pt 2):136691. doi: 10.1016/j.ijbiomac.2024.136691. Epub 2024 Oct 20.
Intestinal tract is the largest immune system of human body. Gut microbiota (GM) can produce a large number of metabolites, such as short-chain fatty acids and bile acids, which regulate the physiological health of the host and affect the development of disease. In recent years, traditional Chinese medicine (TCM) polysaccharides have attracted extensive attention with multiple biological activities and low toxicity. TCM polysaccharides can promote the growth of intestinal beneficial bacteria and inhibit the growth of harmful bacteria by regulating the structure and function of GM, thus playing a crucial role in preventing or treating chronic diseases such as inflammatory bowel disease (IBD), obesity, type 2 diabetes mellitus (T2DM), liver diseases, cancer, etc. In this paper, the research progress of TCM polysaccharides in the treatment of chronic diseases such as inflammatory bowel disease, obesity, T2DM, liver diseases, cancer, etc. by modulating GM was reviewed. Meanwhile, this review makes an in-depth discussion on the shortcomings of the research of TCM polysaccharides on chronic diseases by modulating GM, and new valuable prospection for the future researches of TCM polysaccharides are proposed, which will provide new ideas for the further study of TCM polysaccharides.
肠道是人体最大的免疫系统。肠道微生物群(GM)可产生大量代谢产物,如短链脂肪酸和胆汁酸,它们调节宿主的生理健康并影响疾病的发展。近年来,中药多糖因其多种生物活性和低毒性而受到广泛关注。中药多糖可通过调节GM的结构和功能来促进肠道有益菌的生长并抑制有害菌的生长,从而在预防或治疗诸如炎症性肠病(IBD)、肥胖症、2型糖尿病(T2DM)、肝脏疾病、癌症等慢性疾病中发挥关键作用。本文综述了中药多糖通过调节GM治疗炎症性肠病、肥胖症、T2DM、肝脏疾病、癌症等慢性疾病的研究进展。同时,本综述对中药多糖通过调节GM治疗慢性疾病的研究不足进行了深入探讨,并对中药多糖未来的研究提出了新的有价值的展望,这将为中药多糖的进一步研究提供新思路。